Skip to main content

Table 2 Demographics, surgical and anesthetic characteristics

From: Effects of changes in intraoperative management on recovery from anesthesia: a review of practice improvement initiative

 

Epoch I*

Epoch II*

P

N = 2,936

N = 3,137

 

Age, years

54.8 ± 16.8

54.9 ± 16.8

0.765

Male sex

1,539 (52.5)

1,689 (53.8)

0.291

ASA-PS

  

0.008

 I

267 (9.1)

313 (10.0)

 

 II

1,686 (57.4)

1,731 (55.2)

 

 III

945 (32.2)

1,019 (32.5)

 

 IV

38 (1.3)

74 (2.4)

 

BMI, kg/m2

29.7 ± 7.7

29.4 ± 7.6

0.234

Surgical type

  

0.054

 General

1,070 (36.4)

1,034 (33.0)

 

 Head/Neck

674 (23.0)

811 (25.8)

 

 Urology

613 (20.9)

642 (20.5)

 

 Ophthalmology

180 (6.1)

174 (5.5)

 

 Plastics

168 (5.7)

205 (6.5)

 

 Gastrointestinal

157 (5.4)

190 (6.1)

 

 Orthopedics

50 (1.7)

53 (1.7)

 

 Neurosurgical

13 (0.4)

12 (0.4)

 

 Thoracic

11 (0.4)

16 (0.5)

 

Surgery duration, minutes

129 ± 97

125 ± 93.1

0.131

Intraoperative opioids, iv ME, mg

25 [10,35]

25 [15,35]

<0.001

Intraoperative ketorolac

407 (13.9)

516 (16.5)

0.005

NDMR use

1,594 (54.3)

1,848 (58.9)

<0.001

Neuraxial analgesia used

88 (3.0)

119 (3.8)

0.090

Intraoperative use:

   

Bronchodilators

41 (1.4)

64 (2.0)

0.061

Antihypertensives

442 (15.1)

481 (15.3)

0.775

Antiarrhythmics

7 (0.2)

4 (0.1)

0.775

Vasopressors

41 (1.4)

64 (2.0)

0.061

  1. *All patients underwent surgery/procedures under general anesthesia and few had supplemental neuraxial analgesia. NDMR was reversed with neostigmine 1,500 (94.1%) cases during Epoch I and 1,724 (93.3%) during Epoch II where NDMR were used, P = 0.673. Data presented as mean ± standard deviation; number (percentage), or median [25%,75%]. Abbreviations: ASA = American Society of Anesthesiologists Physical Status; BMI = body mass index; iv ME = intravenous morphine equivalents; NDMR = nondepolarizing muscle relaxant